A randomized, double‐blind, placebo‐controlled, parallel‐group 12‐week pilot phase II trial of SaiLuoTong (SLT) for cognitive function in older adults with mild cognitive impairment

INTRODUCTION: This study primarily aimed to evaluate the efficacy and safety of SaiLuoTong (SLT) on cognition in mild cognitive impairment (MCI). METHODS: Community‐dwelling people with MCI aged ≥60 years were randomly assigned to 180 mg/day SLT or placebo for 12 weeks. RESULTS: Thirty‐nine particip...

Descripción completa

Detalles Bibliográficos
Autores principales: Steiner‐Lim, Genevieve Z., Bensoussan, Alan, Andrews‐Marney, Elana R., Al‐Dabbas, Mahmoud A., Cave, Adele E., Chiu, Christine L., Christofides, Katerina, De Blasio, Frances M., Dewsbury, Lauren S., Fagan, Naomi L., Fogarty, Jack S., Hattom, Lena C., Hohenberg, Mark I., Jafar, Deyyan, Karamacoska, Diana, Lim, Chai K., Liu, Jianxun, Metri, Najwa‐Joelle, Oxenham, D. Vincent, Ratajec, Holly, Roy, Nikita, Shipton, Danielle G., Varjabedian, David, Chang, Dennis H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565903/
https://www.ncbi.nlm.nih.gov/pubmed/37830013
http://dx.doi.org/10.1002/trc2.12420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565903/
https://www.ncbi.nlm.nih.gov/pubmed/37830013
http://dx.doi.org/10.1002/trc2.12420

Ejemplares similares